Articles with public access mandates - Pip PatrickLearn more
Not available anywhere: 3
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
KM Ardeshna, W Qian, P Smith, N Braganca, L Lowry, P Patrick, J Warden, ...
The lancet oncology 15 (4), 424-435, 2014
Mandates: Cancer Research UK, National Institute for Health Research, UK
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study …
PJ Hoskin, L Lowry, A Horwich, A Jack, B Mead, BW Hancock, P Smith, ...
Journal of Clinical Oncology 27 (32), 5390-5396, 2009
Mandates: Cancer Research UK
Basic HTML Version
T Creasey, E Barretta, SL Ryan, E Butler, AA Kirkwood, D Leongamornlert, ...
Haematologica 107, 2051, 2022
Mandates: Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Available somewhere: 17
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma
P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ...
New England Journal of Medicine 374 (25), 2419-2429, 2016
Mandates: Cancer Research UK
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
B Patel, AA Kirkwood, A Dey, DI Marks, AK McMillan, TF Menne, ...
Leukemia 31 (1), 58-64, 2017
Mandates: Blood Cancer UK, Cancer Research UK
Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
RA Anderson, R Remedios, AA Kirkwood, P Patrick, L Stevens, ...
The Lancet Oncology 19 (10), 1328-1337, 2018
Mandates: Cancer Research UK, UK Medical Research Council
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma
SF Barrington, JE Mackewn, P Schleyer, PK Marsden, NG Mikhaeel, ...
Annals of oncology 22 (3), 739-745, 2011
Mandates: Cancer Research UK
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
AV Moorman, E Barretta, ER Butler, EJ Ward, K Twentyman, AA Kirkwood, ...
Leukemia 36 (3), 625-636, 2022
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK …
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
T Illidge, C Chan, N Counsell, S Morris, J Scarisbrick, D Gilson, B Popova, ...
British journal of cancer 109 (10), 2566-2573, 2013
Mandates: Cancer Research UK
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma
S Rule, G Cook, NH Russell, A Hunter, S Robinson, N Morley, A Sureda, ...
British Journal of Haematology 184 (6), 999-1005, 2019
Mandates: Cancer Research UK
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre …
DI Marks, AA Kirkwood, CJ Rowntree, M Aguiar, KE Bailey, B Beaton, ...
The Lancet Haematology 9 (4), e262-e275, 2022
Mandates: Blood Cancer UK, Cancer Research UK
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission …
DI Marks, L Clifton-Hadley, M Copland, J Hussain, TF Menne, A McMillan, ...
The Lancet Haematology 9 (4), e276-e288, 2022
Mandates: Cancer Research UK
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ …
T Creasey, E Barretta, SL Ryan, E Butler, AA Kirkwood, D Leongamornlert, ...
Haematologica 107 (9), 2051, 2022
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK …
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
D Leongamornlert, J Gutiérrez-Abril, SW Lee, E Barretta, T Creasey, ...
Blood Advances 7 (15), 3862-3873, 2023
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK …
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial
RJ Mitchell, AA Kirkwood, E Barretta, L Clifton-Hadley, E Lawrie, SW Lee, ...
Blood Advances 5 (17), 3322-3332, 2021
Mandates: US National Institutes of Health, Blood Cancer UK, Cancer Research UK
Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study
E Das-Gupta, KJ Thomson, AJC Bloor, AD Clark, S Mackinnon, I Kayani, ...
Blood Advances 3 (24), 4264-4270, 2019
Mandates: Cancer Research UK, National Institute for Health Research, UK
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation
R Hough, A Lopes, P Patrick, N Russell, K Raj, E Tholouli, J A. Snowden, ...
Blood Advances 6 (7), 2414-2426, 2022
Mandates: Cancer Research UK
Treatment of classical Hodgkin lymphoma in young adults aged 18–30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial …
W Townsend, S Leong, P Hoskin, P Diez, P Patrick, D Linch, WL Wong, ...
British Journal of Haematology 189 (1), 128-132, 2020
Mandates: Cancer Research UK
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
B Patel, AA Kirkwood, CJ Rowntree, KZ Alapi, E Barretta, L Clifton‐Hadley, ...
HemaSphere 8 (6), 2024
Mandates: Cancer Research UK
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia
SH Gohil, N Maciocia, P Patrick, T Roberts, N Counsell, P Smith, ...
Leukemia & Lymphoma 59 (7), 1730-1733, 2018
Mandates: Cancer Research UK
Publication and funding information is determined automatically by a computer program